Gladius Capital Management LP Invests $42,000 in Enhabit, Inc. (NYSE:EHAB)

Gladius Capital Management LP bought a new stake in shares of Enhabit, Inc. (NYSE:EHAB) during the 4th quarter, HoldingsChannel.com reports. The fund bought 4,092 shares of the company’s stock, valued at approximately $42,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. SG Americas Securities LLC grew its stake in shares of Enhabit by 258.5% during the third quarter. SG Americas Securities LLC now owns 41,438 shares of the company’s stock valued at $466,000 after buying an additional 29,880 shares during the last quarter. Shikiar Asset Management Inc. grew its position in Enhabit by 90.2% during the 3rd quarter. Shikiar Asset Management Inc. now owns 54,600 shares of the company’s stock worth $614,000 after acquiring an additional 25,900 shares during the last quarter. Orion Portfolio Solutions LLC increased its stake in Enhabit by 5.3% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 75,608 shares of the company’s stock worth $851,000 after purchasing an additional 3,795 shares during the period. Illinois Municipal Retirement Fund bought a new stake in Enhabit in the third quarter valued at approximately $334,000. Finally, Barclays PLC boosted its stake in shares of Enhabit by 117.7% during the third quarter. Barclays PLC now owns 104,350 shares of the company’s stock valued at $1,174,000 after purchasing an additional 56,410 shares during the period.

Enhabit Trading Down 14.5 %

Shares of NYSE:EHAB traded down $1.41 on Thursday, hitting $8.29. The company had a trading volume of 3,213,086 shares, compared to its average volume of 572,319. Enhabit, Inc. has a 1 year low of $7.12 and a 1 year high of $14.59. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.76. The firm’s 50-day simple moving average is $10.37 and its two-hundred day simple moving average is $10.02. The firm has a market capitalization of $415.83 million, a price-to-earnings ratio of -5.12, a P/E/G ratio of 1.56 and a beta of 1.98.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, March 6th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of $0.02 by $0.01. Enhabit had a negative net margin of 7.69% and a positive return on equity of 1.55%. The business had revenue of $260.60 million during the quarter, compared to analyst estimates of $260.30 million. During the same period last year, the business posted $0.32 earnings per share. Equities analysts anticipate that Enhabit, Inc. will post 0.24 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

EHAB has been the topic of several analyst reports. Oppenheimer reaffirmed a “market perform” rating on shares of Enhabit in a research note on Thursday, March 7th. Jefferies Financial Group downgraded shares of Enhabit from a “buy” rating to a “hold” rating and lowered their price objective for the company from $14.00 to $8.75 in a research note on Thursday. Finally, UBS Group raised Enhabit from a “sell” rating to a “neutral” rating and set a $9.50 target price on the stock in a research note on Thursday, March 7th. Two research analysts have rated the stock with a sell rating and five have given a hold rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $11.21.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.